Variation in cardiac screening and management of carcinoid geart disease in the UK and Republic of Ireland.
| dc.contributor.author | Dobson, R | |
| dc.contributor.author | Valle, Juan W | |
| dc.contributor.author | Burgess, M I | |
| dc.contributor.author | Poston, G J | |
| dc.contributor.author | Cuthbertson, D J | |
| dc.date.accessioned | 2015-08-12T14:41:08Z | en |
| dc.date.available | 2015-08-12T14:41:08Z | en |
| dc.date.issued | 2015-07-10 | en |
| dc.identifier.citation | Variation in Cardiac Screening and Management of Carcinoid Heart Disease in the UK and Republic of Ireland. 2015: Clin Oncol | en |
| dc.identifier.issn | 1433-2981 | en |
| dc.identifier.pmid | 26170123 | en |
| dc.identifier.doi | 10.1016/j.clon.2015.06.016 | en |
| dc.identifier.uri | http://hdl.handle.net/10541/566203 | en |
| dc.description.abstract | Screening for carcinoid heart disease is an important, yet frequently neglected aspect of the management of patients with neuroendocrine tumours (NETs). Screening is advocated in international guidelines, although recommendations on the modality and frequency are poorly defined. We mapped current practice for the screening and management of carcinoid heart disease in specialist NET centres throughout the UK and Republic of Ireland. | |
| dc.language | ENG | en |
| dc.language.iso | en | en |
| dc.rights | Archived with thanks to Clinical oncology (Royal College of Radiologists (Great Britain)) | en |
| dc.title | Variation in cardiac screening and management of carcinoid geart disease in the UK and Republic of Ireland. | en |
| dc.type | Article | en |
| dc.contributor.department | Neuroendocrine Tumour Group, University Hospital Aintree, Liverpool, UK | en |
| dc.identifier.journal | Clinical Oncology | en |
| html.description.abstract | Screening for carcinoid heart disease is an important, yet frequently neglected aspect of the management of patients with neuroendocrine tumours (NETs). Screening is advocated in international guidelines, although recommendations on the modality and frequency are poorly defined. We mapped current practice for the screening and management of carcinoid heart disease in specialist NET centres throughout the UK and Republic of Ireland. |